
GC73131
Dalmelitinib
Also known as 9-[[8-fluoro-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]-4-methyl-[1,4]oxazino[3,2-c]quinolin-3-one
Dalmelitinib is an orally active selective c-Met kinase inhibitor (IC50: 2·9 nM) that binds to the ATP-binding region of c-Met
ChemicalCAS1637658-98-0MW461.47FormulaC22H16FN7O2S
- CAS number
- 1637658-98-0
- Molecular weight
- 461.47
- Formula
- C22H16FN7O2S
- Solubility
- DMSO : 100 mg/mL (216·70 mM; ultrasonic and warming and heat to 80°C)
- InChIKey
- MFEXYTURXUZOID-UHFFFAOYSA-N
- Catalogue number
- GC73131
- Brand
- GLPBIO
Computed properties PubChem CID 86302574 · XLogP 3 · TPSA 116 Ų · H-bond donors 0
- XLogP
- 3
- TPSA
- 116 Ų
- H-bond donors
- 0
- H-bond acceptors
- 8
- Rotatable bonds
- 3
- Heavy atoms
- 33
SMILES CN1C=C(C=N1)C2=CN3C(=NN=C3SC4=CC5=C6C(=CN=C5C=C4)N(C(=O)CO6)C)C(=C2)F
Computed descriptors from PubChem (CID 86302574), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il